I wonder how it(prurisol) could be scrapped after a company stament(part of a pr) containing this:
"Cellceutix would also like to share some observations and comments from Principle Investigators (PIs) overseeing different participating clinical sites in the trial. Numerous PIs noted patients expressed a desire to have access to Prurisol following the study’s conclusion. Moreover, the Company learned that some patients were previously unsuccessfully treated with other therapies, including biologics and apremilast (Otezla®).
Included below is a sampling of responses that were authorized to be published:
“Well designed study, patients were pleased, minimal to no side effects."
“Good tolerability was shown with very few AEs reported. Good compliance and good patient satisfaction.”
“Overall impression of the study is very positive, as well as the patients’ satisfaction.”
When asked, “Why would you choose Prurisol (should it be approved) over another oral compound for psoriasis?” and “Why would you choose Prurisol over an injectable biologic?” responses included:
“Because [Prurisol] does not cause any severe side effects. Patients dislike needles and injections because they cause pain and discomfort."
“Patients overall prefer oral medications over injectable medication. Our experience with injectable studies for other indications has been that many subjects do not like taking them and those studies tend to be difficult compared to oral medications to recruit subjects.”
“Because of [Prurisol’s] low side effect profile.”
“Patients prefer oral treatments.”
I can only guess whatever the after effects were that happened after the pr? Then there was a poster who, in August of 2017, "made contact" with a patient in the study who was estatic about P results. Maybe that poster is one of the couple of "intelligent investors"(can't remember if the adjective was intelligent(wise, expert, etc) who correspond with management frequently, made by a frequent poster recently(last two days(you responded to the poster)).
Maybe the ceo will elect to forgo his salary for a bit while the finances get worked out in order to get the deal cut?. I've only read about one company who has taken that route(I don't mean ctix).
